首页> 外文期刊>Drug and alcohol dependence >Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder
【24h】

Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder

机译:住宅治疗对阿片类药物使用障碍有效吗?纵向比较阿片类药物依赖型,阿片类药物滥用和非阿片类药物使用成年药物滥用障碍的成年人

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Opioid misuse and dependence rates among emerging adults have increased substantially. While office-based opioid treatments (e.g., buprenorphinealoxone) have shown overall efficacy, discontinuation rates among emerging adults are high. Abstinence-based residential treatment may serve as a viable alternative, but has seldom been investigated in this age group.Methods: Emerging adults attending 12-step-oriented residential treatment (N = 292; 18-24 years, 74% male, 95% White) were classified into opioid dependent (OD; 25%), opioid misuse (OM; 20%), and no opiate use (NO; 55%) groups. Paired t-tests and ANOVAs tested baseline differences and whether groups differed in their during-treatment response. Longitudinal multilevel models tested whether groups differed on substance use outcomes and treatment utilization during the year following the index treatment episode. Results: Despite a more severe clinical profile at baseline among OD, all groups experienced similar during-treatment increases on therapeutic targets (e.g., abstinence self-efficacy), while OD showed a greater decline in psychiatric symptoms. During follow-up relative to OM, both NO and OD had significantly greater Percent Days Abstinent, and significantly less cannabis use. OD attended significantly more outpatient treatment sessions than OM or NO; 29% of OD was completely abstinent at 12-month follow-up.Conclusions: Findings here suggest that residential treatment may be helpful for emerging adults with opioid dependence. This benefit may be less prominent, though, among non-dependent opioid misusers. Randomized trials are needed to compare more directly the relative benefits of outpatient agonist-based treatment to abstinence-based, residential care in this vulnerable age-group, and to examine the feasibility of an integrated model.
机译:背景:阿片类药物滥用和成年成年人的依赖率大大增加。虽然基于办公室的阿片类药物治疗(例如丁丙诺啡/纳洛酮)已显示出整体疗效,但新兴成年人的停药率很高。以禁欲为基础的住院治疗可能是一种可行的选择,但在这一年龄段很少进行研究。方法:接受12步定向住院治疗的新兴成年人(N = 292; 18-24岁,男性74%,95%白色)分为阿片类药物依赖型(OD; 25%),阿片类药物滥用(OM; 20%)和无鸦片类药物使用(NO; 55%)。配对的t检验和方差分析检验了基线差异以及各组在治疗期间反应中是否存在差异。纵向多层次模型测试了指数治疗发作后一年内各组在药物使用结果和治疗利用方面是否存在差异。结果:尽管OD的基线临床情况更为严重,但所有组在治疗过程中的治疗目标均出现相似的增加(例如节制自我效能),而OD表现出更大的精神症状下降。在相对于OM的随访期间,NO和OD的禁食日数均显着增加,并且大麻使用量显着减少。与OM或NO相比,OD参加的门诊治疗要多得多。在12个月的随访中,完全戒断了OD的29%。结论:这里的发现表明,住院治疗可能对新兴的阿片类药物依赖的成年人有帮助。但是,在非依赖性阿片类药物滥用者中,这种益处可能不太明显。需要进行随机试验,以更直接地比较在这个脆弱年龄组中,基于激动剂的门诊治疗与基于禁欲的住院治疗的相对利益,并检验整合模型的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号